Zeneca - Search News

AstraZeneca, breast cancer

Reuters on MSN · 1d

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

AstraZeneca Gets Full FDA Approval for CMS-Selected Lymphoma Treatment

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the 15 products to be subject to IRA-prescripted price negotiations for Medicare this year.

Business Insider · 22h

FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer

The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Daiichi Sankyo's (DSKYF.PK) Datroway (datopotamab

MarketWatch · 1d

AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

1don MSN

AstraZeneca overhauls management of its China division, FT reports

AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general ...

1d

AstraZeneca Aims to Restore Trust With New Leadership in China Amid Scandal and Sales Decline

AstraZeneca restructures its China operations following leadership scandals and sales challenges, appointing new executives ...

2d

Harnessing AI and data science to discover life-changing medicines at AstraZeneca

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

2d

Kepler Capital Remains a Hold on AstraZeneca (AZN)

In a report released on January 15, David Evans from Kepler Capital maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...

Crypto News Flash7d

How a Crypto Investor Made $2.5M Trading AI Tokens

A crypto investor shares how AI agents drive innovation and new opportunities in the blockchain space. Diversification and ...

2d

AstraZeneca rises Thursday, outperforms market

Shares of AstraZeneca PLC AZN rallied 1.84% to £108.44 Thursday, on what proved to be an all-around positive trading session ...

News Medical on MSN2d

AstraZeneca's Pioneering Research in Heart Failure and ATTR-CM: An interview with Mina Maker

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

1d

AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab

AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...

3d

AstraZeneca rises Wednesday, still underperforms market

Shares of AstraZeneca PLC AZN inched up 0.17% to £106.48 Wednesday, on what proved to be an all-around positive trading ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results